StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
12
Publishing Date
2023 - 06 - 21
1
2023 - 04 - 26
2
2023 - 01 - 30
1
2023 - 01 - 06
1
2022 - 10 - 25
2
2022 - 03 - 21
1
2021 - 11 - 05
1
2021 - 05 - 21
2
2021 - 03 - 29
1
Sector
Consumer non-durables
1
Distribution services
1
Health technology
12
Process industries
1
Tags
Abbvie
7
Active
10
Agreement
10
America
46
Antibiotics
7
Antibody
9
Application
9
Approval
10
Biotech
26
Cancer
54
Care
11
Collaboration
11
Covid
34
Covid-19
25
Device
11
Diabetes
7
Disease
39
Distribution
11
Drug
110
Drug delivery
12
Earnings
7
Ema
7
Europe
17
Expected
28
Fda
14
Food
22
Genetown
9
Global
159
Growing
34
Growth
192
Health
22
Hiv
12
Infection
10
Infections
9
Influenza
9
Iot
19
License
10
Liver
15
Market
447
Merge
11
N/a
792
Nutrition
12
People
16
Pharma
11
Pharmaceuticals
12
Positive
12
Reach
24
Report
140
Research
88
Respiratory
16
Results
19
Risk
8
Set
14
System
11
Technology
23
Therapeutics
84
Therapy
24
Treatment
98
Trial
13
Vaccine
56
Entities
Abbott laboratories
1
Agenus inc.
1
Archer-daniels-midland company
1
Curevac n.v.
2
Eli lilly and company
3
General mills, inc.
1
Glaxosmithkline plc
12
Herbalife nutrition ltd.
1
Pfizer, inc.
1
Sanofi
3
Vir biotechnology, inc.
3
Zai lab limited
1
Zentalis pharmaceuticals, inc.
2
Symbols
ABBV
31
ADIL
10
ALNY
19
ALPMF
14
ALPMY
14
AMGN
14
ANVS
10
AQST
18
ARVL
21
AZN
13
BBIO
16
BGNE
19
BIIB
13
BMY
27
BNTX
17
BYSI
11
CHRS
21
CLDX
10
CLSD
15
DARE
13
FBIO
10
FNCTF
21
GILD
13
GSK
12
HOTH
14
IMMP
12
IMMX
10
INCY
15
IONS
21
IT
12
JNJ
46
LLY
30
LTUM
14
MDWD
11
MRK
19
MS
10
MYOV
10
NDAQ
42
NVS
20
NVSEF
16
PFE
45
PLRX
10
PPRUF
11
PPRUY
11
RCKT
11
RDHL
10
REGN
26
RGNX
17
RNAZ
10
SCYX
11
SLS
11
SNY
103
SNYNF
79
SRNE
19
TAK
15
TAYD
17
TEVJF
14
TNXP
12
VERU
10
VRTX
11
Exchanges
Nasdaq
12
Nyse
12
Crawled Date
2023 - 06 - 21
1
2023 - 04 - 26
2
2023 - 01 - 30
1
2023 - 01 - 06
1
2022 - 10 - 25
2
2022 - 03 - 21
1
2021 - 11 - 05
1
2021 - 05 - 21
2
2021 - 03 - 29
1
Crawled Time
01:00
1
12:15
1
12:20
2
13:00
1
14:00
2
14:20
1
15:00
1
15:20
1
16:00
1
22:00
1
Source
www.biospace.com
5
www.curevac.com
2
www.globenewswire.com
4
www.prnewswire.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Positive
symbols :
Gsk
save search
GSK shares positive data for AREXVY, its respiratory syncytial virus (RSV) older adult vaccine, indicating protection over two RSV seasons
Published:
2023-06-21
(Crawled : 13:00)
- biospace.com/
GSK
|
News
|
$40.86
-0.92%
1.25%
1.6M
|
Health Technology
|
18.02%
|
O:
0.55%
H:
1.09%
C:
0.98%
AGEN
A
|
$7.42
14.86%
12.94%
1.2M
|
Health Technology
|
296.79%
|
O:
0.0%
H:
2.67%
C:
-1.6%
respiratory
positive
rsv
virus
Zentalis to present positive clinical data in ovarian cancer combining azenosertib and chemotherapy, including at the 2023 ASCO Annual Meeting
Published:
2023-04-26
(Crawled : 15:00)
- biospace.com/
GLAXF
|
News
|
$19.54
-3.77%
-14.18%
170
|
Health Technology
|
4.31%
|
O:
-4.57%
H:
0.22%
C:
-1.98%
GSK
|
News
|
$40.86
-0.92%
1.25%
1.6M
|
Health Technology
|
10.7%
|
O:
-0.03%
H:
0.3%
C:
-2.63%
ZNTL
|
$11.77
-6.36%
-6.89%
850K
|
Health Technology
|
-45.98%
|
O:
-0.23%
H:
0.18%
C:
-1.43%
asco
positive
cancer
meeting
Zentalis to present positive clinical data in ovarian cancer combining azenosertib and chemotherapy, including clinical support for Cyclin E1 expression as predictive marker for clinical benefit from azenosertib at the 2023 ASCO Annual Meeting
Published:
2023-04-26
(Crawled : 14:20)
- globenewswire.com
GLAXF
|
News
|
$19.54
-3.77%
-14.18%
170
|
Health Technology
|
4.31%
|
O:
-4.57%
H:
0.22%
C:
-1.98%
GSK
|
News
|
$40.86
-0.92%
1.25%
1.6M
|
Health Technology
|
10.7%
|
O:
-0.03%
H:
0.3%
C:
-2.63%
ZNTL
|
$11.77
-6.36%
-6.89%
850K
|
Health Technology
|
-45.98%
|
O:
-0.23%
H:
0.18%
C:
-1.43%
asco
positive
cancer
meeting
CureVac veröffentlicht positive Daten bei älteren Erwachsenen aus COVID-19- und Grippe-mRNA-Impfstoffentwicklungsprogrammen
Published:
2023-01-30
(Crawled : 12:20)
- curevac.com
GLAXF
|
News
|
$19.54
-3.77%
-14.18%
170
|
Health Technology
|
11.71%
|
O:
-2.59%
H:
3.12%
C:
1.79%
GSK
|
News
|
$40.86
-0.92%
1.25%
1.6M
|
Health Technology
|
15.75%
|
O:
0.74%
H:
0.2%
C:
-1.24%
CVAC
|
$2.51
-3.46%
-3.59%
1.1M
|
Health Technology
|
-77.96%
|
O:
5.36%
H:
4.0%
C:
-3.5%
covid-19
positive
CureVac gibt positive Daten aus gemeinsamen COVID-19- und Grippe-mRNA-Impfstoffentwicklungsprogrammen bekannt
Published:
2023-01-06
(Crawled : 12:20)
- curevac.com
GSK
|
News
|
$40.86
-0.92%
1.25%
1.6M
|
Health Technology
|
18.5%
|
O:
-0.44%
H:
1.85%
C:
1.72%
CVAC
|
$2.51
-3.46%
-3.59%
1.1M
|
Health Technology
|
-60.66%
|
O:
12.7%
H:
15.44%
C:
14.88%
covid-19
positive
Global Nutraceuticals Market Report 2022-2027: Growing Demand for Personalized Nutrition to have Positive Impact
Published:
2022-10-25
(Crawled : 16:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
-3.77%
-14.18%
170
|
Health Technology
|
26.11%
|
O:
5.27%
H:
0.0%
C:
-2.17%
HLF
|
$9.2
-0.43%
0.0%
860K
|
Distribution Services
|
-55.79%
|
O:
0.24%
H:
6.9%
C:
6.42%
GSK
|
News
|
$40.86
-0.92%
1.25%
1.6M
|
Health Technology
|
28.65%
|
O:
0.57%
H:
1.16%
C:
0.94%
GIS
4
|
$71.61
1.12%
0.55%
3.6M
|
Consumer Non-Durables
|
-7.74%
|
O:
-0.26%
H:
1.46%
C:
1.14%
ADM
|
$61.56
-0.37%
0.15%
3M
|
Process Industries
|
-31.05%
|
O:
1.06%
H:
1.58%
C:
1.01%
ABT
|
News
|
$106.89
-0.65%
-0.09%
4.2M
|
Health Technology
|
8.75%
|
O:
-0.22%
H:
0.85%
C:
-0.12%
global
nutrition
report
growing
impact
positive
market
ViiV Healthcare presents positive proof-of-concept findings for N6LS, an investigational, broadly neutralising antibody (bNAb) offering a potential new approach for the treatment of HIV
Published:
2022-10-25
(Crawled : 15:20)
- biospace.com/
GLAXF
|
News
|
$19.54
-3.77%
-14.18%
170
|
Health Technology
|
26.11%
|
O:
5.27%
H:
0.0%
C:
-2.17%
PFE
|
News
4
|
$26.27
-0.19%
0.19%
18M
|
Health Technology
|
-42.31%
|
O:
-0.59%
H:
1.21%
C:
0.71%
GSK
|
News
|
$40.86
-0.92%
1.25%
1.6M
|
Health Technology
|
28.65%
|
O:
0.57%
H:
1.16%
C:
0.94%
offering
treatment
antibody
hiv
potential
positive
Zai Lab Presents Positive Results from Phase 3 PRIME Study of ZEJULA® (Niraparib) at Society of Gynecologic Oncology Meeting
Published:
2022-03-21
(Crawled : 01:00)
- globenewswire.com
GLAXF
|
News
|
$19.54
-3.77%
-14.18%
170
|
Health Technology
|
-2.5%
|
O:
4.8%
H:
4.09%
C:
4.09%
GSK
|
News
|
$40.86
-0.92%
1.25%
1.6M
|
Health Technology
|
-4.31%
|
O:
0.96%
H:
0.0%
C:
0.0%
ZLAB
|
$15.66
3.57%
3.45%
430K
|
Health Technology
|
-55.41%
|
O:
10.34%
H:
0.0%
C:
0.0%
zejula
pos
positive results
positive
results
phase 3
primec
GSK announces positive Phase III efficacy and safety data for daprodustat in patients with anaemia due to chronic kidney disease
Published:
2021-11-05
(Crawled : 22:00)
- biospace.com/
GLAXF
|
News
|
$19.54
-3.77%
-14.18%
170
|
Health Technology
|
-4.98%
|
O:
3.11%
H:
0.0%
C:
0.0%
GSK
|
News
|
$40.86
-0.92%
1.25%
1.6M
|
Health Technology
|
-4.91%
|
O:
0.05%
H:
0.0%
C:
0.0%
disease
positive
kidney
CORRECTION -- EMA Issues Positive Scientific Opinion on GSK and Vir Biotechnology’s Sotrovimab For the Early Treatment of COVID-19
Published:
2021-05-21
(Crawled : 14:00)
- globenewswire.com
GSK
|
News
|
$40.86
-0.92%
1.25%
1.6M
|
Health Technology
|
4.69%
|
O:
-0.26%
H:
0.26%
C:
-0.21%
LLY
|
News
|
$732.2
-1.81%
-0.84%
1.7M
|
Health Technology
|
276.99%
|
O:
0.24%
H:
0.96%
C:
-0.06%
VIR
|
$8.04
-1.11%
-1.12%
770K
|
Health Technology
|
-82.19%
|
O:
1.75%
H:
0.13%
C:
-1.44%
SNY
|
News
|
$46.61
-2.27%
-2.21%
1.6M
|
Health Technology
|
-12.2%
|
O:
-0.43%
H:
0.2%
C:
0.02%
covid
treatment
positive
biotech
technology
iot
ema
EMA Issues Positive Scientific Opinion on GSK and Vir Biotechnology’s Sotrovimab For the Early Treatment of COVID-19
Published:
2021-05-21
(Crawled : 12:15)
- globenewswire.com
GSK
|
News
|
$40.86
-0.92%
1.25%
1.6M
|
Health Technology
|
4.69%
|
O:
-0.26%
H:
0.26%
C:
-0.21%
LLY
|
News
|
$732.2
-1.81%
-0.84%
1.7M
|
Health Technology
|
276.99%
|
O:
0.24%
H:
0.96%
C:
-0.06%
VIR
|
$8.04
-1.11%
-1.12%
770K
|
Health Technology
|
-82.19%
|
O:
1.75%
H:
0.13%
C:
-1.44%
SNY
|
News
|
$46.61
-2.27%
-2.21%
1.6M
|
Health Technology
|
-12.2%
|
O:
-0.43%
H:
0.2%
C:
0.02%
covid
treatment
positive
biotech
technology
iot
ema
Lilly, Vir Biotechnology and GSK Announce Positive Topline Data from the Phase 2 BLAZE-4 Trial Evaluating Bamlanivimab with VIR-7831 in Low-Risk Adults with COVID-19
Published:
2021-03-29
(Crawled : 14:00)
- biospace.com/
GSK
|
News
|
$40.86
-0.92%
1.25%
1.6M
|
Health Technology
|
11.43%
|
O:
-0.82%
H:
1.18%
C:
0.88%
LLY
|
News
|
$732.2
-1.81%
-0.84%
1.7M
|
Health Technology
|
305.92%
|
O:
-0.35%
H:
1.63%
C:
0.91%
VIR
|
$8.04
-1.11%
-1.12%
770K
|
Health Technology
|
-84.4%
|
O:
-1.46%
H:
1.02%
C:
-4.73%
SNY
|
News
|
$46.61
-2.27%
-2.21%
1.6M
|
Health Technology
|
-4.4%
|
O:
-0.56%
H:
0.83%
C:
0.57%
covid
phase 2
risk
positive
topline
biotech
technology
iot
trial
Gainers vs Losers
61%
39%
Top 10 Gainers
CSSE
4
|
$0.4253
179.25%
64.77%
210M
|
Consumer Services
BOF
|
$2.08
77.78%
41.21%
110M
|
ILAG
|
$0.54
12.27%
40.62%
3.7M
|
LICN
|
$0.999
78.39%
40.49%
15M
|
AMST
|
$3.4
70.0%
39.58%
70M
|
Technology Services
MTC
|
$3.6
60.71%
38.04%
9.1M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.458
14.5%
30.92%
91K
|
Health Services
WHLM
|
$6.25
35.87%
28.46%
700K
|
Commercial Services
MULN
|
News
|
$3.77
38.1%
27.78%
13M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.